Pregnancy News and Research

Latest Pregnancy News and Research

Quidel acquires Diagnostic Hybrids for $130 million

Quidel Corporation, a leading provider of rapid diagnostic tests, has completed its previously announced acquisition of Diagnostic Hybrids, Inc. for approximately $130 million in cash.

20 Feb 2010

10th Annual Conference for Young Women Affected by Breast Cancer

Young women diagnosed with breast cancer are uniquely impacted by issues often not faced by older women. Breast cancer is often detected at later stages, increasing diagnoses of more advanced cancers. The impact of cancer treatment on fertility, body image, financial challenges, and slightly higher mortality rates are significant concerns for this population.

19 Feb 2010

Patient registry formed to track clinical course of hypoactive sexual desire disorder

New findings from a European study show that women with low sexual desire and associated distress experience personal and emotional distress related to the sexual issue.

19 Feb 2010

Group B streptococcus may have significant public health implications: Study

A common bacteria found in many healthy adult females that can cause life-threatening infections when passed to newborns could be introduced to some women through frequent contact with cows, according to a research team led by a Michigan State University pediatrician.

19 Feb 2010

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Novartis announced today that Tasigna® (nilotinib) 200 mg capsules has been granted priority review by the US Food and Drug Administration for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase.

19 Feb 2010

Efficient healthcare system in sub-Saharan Africa can reduce maternal deaths

More than 500,000 women die each year worldwide due to complications arising from pregnancy and childbirth. Half of these women live in sub-Saharan Africa. A research team from the King Juan Carlos University (URJC) in Madrid says these women are not dying as a result of any illness, but rather from a lack of basic healthcare measures.

19 Feb 2010

Steroids and weight loss products can accelerate hair loss, says hair loss expert

In a study due to be released next month, the world's leading hair transplant and hair loss expert Dr. Larry Shapiro will show that men and women have been losing their hair from using popular weight loss and work out products that contain whey protein isolate- and it's not just their genes that are to blame.

19 Feb 2010

Revised and updated edition of Toole's Cerebrovascular Disorders textbook now available

Since it was published more than 40 years ago, Toole's Cerebrovascular Disorders has been a standard textbook for the prevention, diagnosis and treatment of strokes.

18 Feb 2010

UCSF receives $1.15M grant to integrate family planning into HIV treatment and care

UCSF has received a $1.15 million grant from the Bill & Melinda Gates Foundation to determine if integrating family planning into HIV treatment and care will increase contraceptive use and decrease unintended pregnancy among HIV-positive women. UCSF will partner with the Kenya Medical Research Institute and Ibis Reproductive Health to conduct the research.

18 Feb 2010

Researcher develops acoustic resonant sensor that can test bodily fluids for variety of diseases

What if it were possible to go to the store and buy a kit to quickly and accurately diagnose cancer, similar to a pregnancy test? A University of Missouri researcher is developing a tiny sensor, known as an acoustic resonant sensor, that is smaller than a human hair and could test bodily fluids for a variety of diseases, including breast and prostate cancers.

18 Feb 2010

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

Gilead Sciences, Inc. announced Phase II clinical trial results today showing that its investigational fixed-dose single-tablet “Quad” regimen of elvitegravir, GS 9350 (cobicistat) and Truvada® (emtricitabine and tenofovir disoproxil fumarate) for the treatment of HIV infection exhibited antiretroviral activity comparable to that of Atripla® (efavirenz 600 mg/ emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg).

18 Feb 2010

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Merck & Co., Inc. announced today that in new Phase III data, GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] was 77.5 percent (95 percent CI: 39.6, 93.3) efficacious against anal intraepithelial neoplasia (AIN) associated with human papillomavirus (HPV) types 6, 11, 16 and 18 in 16-to-26 year-old men who have sex with men. The data were presented at the European Research Organization on Genital Infection and Neoplasia (EUROGIN) conference in Monte Carlo, Monaco.

18 Feb 2010

Phase 3b ODIN study of once-daily PREZISTA in HIV-1 adults presented at CROI 2010

In a new study of treatment-experienced HIV-1-infected adults with no PREZISTA® (darunavir) resistance-associated mutations (RAMs), 72 percent of patients in the PREZISTA/ritonavir (r) (800/100 mg) once-daily arm achieved undetectable viral loads (<50 copies/mL) compared with 71 percent of patients in the PREZISTA/r (600/100 mg) twice-daily arm. The study met its primary objective of non-inferiority. These data from the Phase 3b ODIN study were presented today at CROI 2010, the 17th Conference on Retroviruses and Opportunistic Infections, in San Francisco.

18 Feb 2010

Researchers establish Canadian norms for diagnosing FASD

Fetal Alcohol Research, the official journal of FACE, has published breakthrough research by Dr. Sterling Clarren, CEO and Chief Scientific Officer of Canada Northwest FASD Research Network and colleagues, establishing Canadian norms which will allow more accurate diagnosis of Fetal Alcohol Spectrum Disorder (FASD).

18 Feb 2010

WebMD Health introduces new enhancements for Medscape Mobile for physicians

WebMD Health Corp., the leading source of health information, today announced a set of new enhancements for Medscape Mobile to assist physicians in diagnosis and treatment at the point-of-care. Medscape Mobile, WebMD's free medical application for physicians, now provides access to thousands of in-depth clinical reference articles on diseases, conditions, and procedures, in addition to complete reference information on over 7,000 brand name, generic and OTC medications.

17 Feb 2010

Sequenom CMM launches SensiGene Fetal Sex Determination test

Sequenom, Inc. today announced the launch of the SensiGene™ Fetal(XY) (Fetal Sex Determination) test by Sequenom's CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company's second laboratory developed test powered by its SEQureDx™ technology.

17 Feb 2010

Infants born to bilingual mothers exhibit different language preferences

It may not be obvious, but hearing two languages regularly during pregnancy puts infants on the road to bilingualism by birth. According to new findings in Psychological Science, a journal of the Association for Psychological Science, infants born to bilingual mothers (who spoke both languages regularly during pregnancy) exhibit different language preferences than infants born to mothers speaking only one language.

17 Feb 2010

Researcher receives $2.4M grant from NIH to study preeclampsia and diabetes in pregnant women

The link between obesity and high-risk pregnancies caused by preeclampsia and diabetes will be the focus of a $2.4 million National Institutes of Health research grant received by Sean Blackwell, M.D., associate professor in the Department of Obstetrics, Gynecology, and Reproductive Sciences at The University of Texas Medical School at Houston.

15 Feb 2010

Fourth-quarter and full-year 2009 results announced by Quidel

Quidel Corporation, a leading provider of rapid point-of-care diagnostic tests, announced today financial results for the fourth quarter and full year ended December 31, 2009.

12 Feb 2010

FDA grants approval for Abbott's antiretroviral medication Norvir

Abbott announced today that the U.S. Food and Drug Administration (FDA) has granted approval of a new tablet formulation of the company's antiretroviral medication Norvir ® (ritonavir). The new Norvir tablets can be stored at room temperature and do not require refrigeration, making it more convenient for patients.

11 Feb 2010

Pregnancy News and Research

Latest Pregnancy News and Research

Quidel acquires Diagnostic Hybrids for $130 million

10th Annual Conference for Young Women Affected by Breast Cancer

Patient registry formed to track clinical course of hypoactive sexual desire disorder

Group B streptococcus may have significant public health implications: Study

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Efficient healthcare system in sub-Saharan Africa can reduce maternal deaths

Steroids and weight loss products can accelerate hair loss, says hair loss expert

Revised and updated edition of Toole's Cerebrovascular Disorders textbook now available

UCSF receives $1.15M grant to integrate family planning into HIV treatment and care

Researcher develops acoustic resonant sensor that can test bodily fluids for variety of diseases

Gilead Sciences’ “Quad” regimen for HIV exhibits antiretroviral activity comparable to Atripla

Phase III data reveals potential of Merck’s GARDASIL in preventing HPV and HPV-related cancers

Phase 3b ODIN study of once-daily PREZISTA in HIV-1 adults presented at CROI 2010

Researchers establish Canadian norms for diagnosing FASD

WebMD Health introduces new enhancements for Medscape Mobile for physicians

Sequenom CMM launches SensiGene Fetal Sex Determination test

Infants born to bilingual mothers exhibit different language preferences

Researcher receives $2.4M grant from NIH to study preeclampsia and diabetes in pregnant women

Fourth-quarter and full-year 2009 results announced by Quidel

FDA grants approval for Abbott's antiretroviral medication Norvir

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Pregnancy News and Research

Latest Pregnancy News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in